150 related articles for article (PubMed ID: 16377280)
1. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention.
Chu WW; Rha SW; Kuchulakanti PK; Cheneau E; Torguson R; Pinnow E; Alexieva-Fournadjiev J; Pichard AD; Satler LF; Kent KM; Lindsay J; Waksman R
Am J Cardiol; 2006 Jan; 97(1):34-7. PubMed ID: 16377280
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
[TBL] [Abstract][Full Text] [Related]
3. Comparison of sirolimus-eluting stents with paclitaxel-eluting stents in saphenous vein graft intervention (from a multicenter Southern California Registry).
Lee MS; Hu PP; Aragon J; Shah AP; Oyama J; Dhoot J; Iqbal Z; Jones N; Penny W; Tobis J; Mahmud E; French W
Am J Cardiol; 2010 Aug; 106(3):337-41. PubMed ID: 20643242
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease.
Minutello RM; Bhagan S; Sharma A; Slotwiner AJ; Feldman DN; Cuomo LJ; Wong SC
J Interv Cardiol; 2007 Dec; 20(6):458-65. PubMed ID: 18042050
[TBL] [Abstract][Full Text] [Related]
5. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
[TBL] [Abstract][Full Text] [Related]
6. Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction.
Newell MC; Henry CR; Sigakis CJ; Unger BT; Larson DM; Chavez IJ; Burke MN; Traverse JH; Henry TD
Am J Cardiol; 2006 May; 97(9):1299-302. PubMed ID: 16635599
[TBL] [Abstract][Full Text] [Related]
7. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents.
Kuchulakanti PK; Torguson R; Chu WW; Canos DA; Rha SW; Clavijo L; Deible R; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
Am J Cardiol; 2006 Mar; 97(6):792-7. PubMed ID: 16516578
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention.
Chu WW; Kuchulakanti PK; Wang B; Clavijo LC; Suddath WO; Pichard AD; Satler LF; Kent KM; Waksman R
J Interv Cardiol; 2006 Apr; 19(2):121-5. PubMed ID: 16650239
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
Daemen J; Tanimoto S; García-García HM; Kukreja N; van de Sande M; Sianos G; de Jaegere PP; van Domburg RT; Serruys PW
Am J Cardiol; 2007 Apr; 99(8):1027-32. PubMed ID: 17437722
[TBL] [Abstract][Full Text] [Related]
10. Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
Pucelikova T; Mehran R; Kirtane AJ; Kim YH; Fahy M; Weisz G; Lansky AJ; Moussa I; Gray WA; Collins MB; Kodali SK; Stone GW; Moses JW; Leon MB; Dangas G
Am J Cardiol; 2008 Jan; 101(1):63-8. PubMed ID: 18157967
[TBL] [Abstract][Full Text] [Related]
11. Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study.
Ellis SG; Kandzari D; Kereiakes DJ; Pichard A; Huber K; Resnic F; Yakubov S; Callahan K; Borgman M; Cohen SA
J Invasive Cardiol; 2007 Oct; 19(10):404-9. PubMed ID: 17906340
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease.
Hoye A; Lemos PA; Arampatzis CA; Saia F; Tanabe K; Degertekin M; Hofma S; McFadden E; Sianos G; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Serruys PW
J Invasive Cardiol; 2004 May; 16(5):230-3. PubMed ID: 15152123
[TBL] [Abstract][Full Text] [Related]
13. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W
Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts.
Okabe T; Lindsay J; Buch AN; Steinberg DH; Roy P; Slottow TL; Smith K; Torguson R; Xue Z; Satler LF; Kent KM; Pichard AD; Weissman NJ; Waksman R
Am J Cardiol; 2008 Sep; 102(5):530-4. PubMed ID: 18721507
[TBL] [Abstract][Full Text] [Related]
15. Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
Chu WW; Kuchulakanti PK; Torguson R; Wang B; Clavijo LC; Suddath WO; Pichard AD; Satler LF; Kent KM; Waksman R
Catheter Cardiovasc Interv; 2006 Jul; 68(1):62-6. PubMed ID: 16755592
[TBL] [Abstract][Full Text] [Related]
16. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
17. Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study).
Maresta A; Varani E; Balducelli M; Varbella F; Lettieri C; Uguccioni L; Sangiorgio P; Zoccai GB;
Am J Cardiol; 2008 Jun; 101(11):1560-6. PubMed ID: 18489933
[TBL] [Abstract][Full Text] [Related]
18. Early outcome of treatment of ostial de novo left anterior descending coronary artery lesions with drug-eluting stents.
Tsagalou E; Stankovic G; Iakovou I; Melzi G; Cosgrave J; Ge L; Michev I; Chieffo A; Airoldi F; Carlino M; Montorfano M; Colombo A
Am J Cardiol; 2006 Jan; 97(2):187-91. PubMed ID: 16442360
[TBL] [Abstract][Full Text] [Related]
19. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
Weisz G; Moses JW; Teirstein PS; Holmes DR; Raizner AE; Satler LF; Mishkel G; Wilensky RL; Wang P; Kuntz RE; Popma JJ; Leon MB
Am J Cardiol; 2007 Apr; 99(8):1044-50. PubMed ID: 17437725
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]